{"gene":"LMF1","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2007,"finding":"LMF1 (encoded by Tmem112/Lmf1) is a transmembrane protein localized to the endoplasmic reticulum (ER) that is required for post-translational maturation of lipoprotein lipase (LPL) and hepatic lipase (HL); loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in mice (cld mutation) and humans.","method":"Positional cloning of cld mutation, ER localization studies, lipase activity assays in mice and human patient with homozygous LMF1 mutation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — original discovery with multiple orthogonal methods (positional cloning, localization, biochemical activity), replicated in mouse and human","pmids":["17994020"],"is_preprint":false},{"year":2009,"finding":"LMF1 adopts a five-transmembrane topology in the ER membrane, dividing it into six domains: three cytoplasmic (N-terminal domain, loops B and D) and three ER-luminal (loops A and C, C-terminal domain). The evolutionarily conserved DUF1222 domain spans four of these six domains, and LMF1 physically interacts with LPL and hepatic lipase through loop C within DUF1222.","method":"Ectopic glycan attachment site tagging, GFP terminal fusion, naturally occurring DUF1222 truncation variants, co-immunoprecipitation/pulldown assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — topology established by multiple experimental strategies (glycosylation tagging + GFP fusions), interaction site mapped by loss-of-function variants","pmids":["19783858"],"is_preprint":false},{"year":2012,"finding":"Overexpression of Lmf1 in adipose tissue (aP2-Lmf1 transgenic) and muscle (Mck-Lmf1 transgenic) increases LPL activity in vivo, demonstrating that variation in Lmf1 expression is a post-translational determinant of LPL activity beyond its role as a required maturation factor.","method":"Transgenic mouse generation and characterization; LPL activity and mass measurements in multiple tissues; association of LMF1 gene variants with post-heparin LPL activity in human dyslipidemic cohort","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — clean transgenic gain-of-function with defined biochemical phenotype in multiple tissues, supported by human genetic association","pmids":["22345169"],"is_preprint":false},{"year":2014,"finding":"LMF1 expression is induced by ER stress via the ATF6α arm of the unfolded protein response (UPR); ATF6α is both sufficient and necessary for activation of the Lmf1 promoter through a GC-rich cis-regulatory element 264 bp upstream of the transcriptional start site.","method":"Genetic deficiency in mouse embryonic fibroblasts and mouse liver, luciferase reporter assays, tunicamycin-treated mice, dominant-negative ATF6α, ATF6α knockout","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic dissection using genetic ablation, reporter assays, and dominant-negative approaches across multiple cell types","pmids":["25035425"],"is_preprint":false},{"year":2014,"finding":"LMF1 is required for maturation of endothelial lipase (EL) in addition to LPL and hepatic lipase; LMF1-null mice (complete knockout) are born at Mendelian ratios but exhibit combined lipase deficiency, hypertriglyceridemia, and neonatal lethality, confirming LMF1 is dispensable for embryonic but not postnatal survival.","method":"LMF1-null mouse generation, in situ hybridization, qPCR, lipase activity assays","journal":"Nutrition & metabolism","confidence":"High","confidence_rationale":"Tier 2 — clean null allele with defined biochemical (lipase deficiency) and physiological (neonatal lethality) phenotype","pmids":["25302068"],"is_preprint":false},{"year":2018,"finding":"Specific LMF1 missense variants (p.Gly172Arg, p.Arg354Trp, p.Arg364Gln, p.Arg537Trp) reduce LPL activity in vitro when co-transfected with LPL in HEK-293T cells, while the p.Trp464Ter nonsense variant completely abolishes LPL activity, establishing functional impact at the cellular level.","method":"In vitro co-transfection of HEK-293T cells with LMF1 and LPL vectors, LPL activity assay using human VLDL-TG as substrate","journal":"Journal of clinical lipidology","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based functional assay with direct LPL activity measurement, single lab","pmids":["30037590"],"is_preprint":false},{"year":2024,"finding":"Homozygous LMF1 variants (p.Asn147Lys, p.Pro246Arg, p.Arg354Trp, p.Arg364Gln) impair LMF1 function by reducing the specific activity of LMF1 as a chaperone for LPL; p.Asn147Lys additionally reduces LMF1 protein expression itself, revealing distinct molecular mechanisms of pathogenic variants.","method":"Transient transfection of HEK293 cells, LPL activity assay, LMF1 protein expression analysis","journal":"Journal of clinical lipidology","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based functional assay with multiple variants and mechanistic distinction, single lab","pmids":["39537501"],"is_preprint":false},{"year":2012,"finding":"LMF1 is an ER protein necessary for folding of LPL into its active dimeric form; its expression in rat adipose tissue does not respond rapidly to feeding/fasting cycles unlike ANGPTL4 and GPIHBP1, indicating its role as a constitutive chaperone rather than a dynamic regulator of LPL activity.","method":"Cycloheximide and actinomycin D chase experiments, qPCR, LPL activity assays in rat adipose tissue under feeding/fasting conditions","journal":"BMC physiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct mRNA and protein turnover experiments establishing LMF1 as a constitutive ER chaperone distinct from regulatory proteins","pmids":["23176178"],"is_preprint":false}],"current_model":"LMF1 is an ER-resident polytopic chaperone with five transmembrane segments whose luminal DUF1222 domain (specifically loop C) physically interacts with nascent LPL, hepatic lipase, and endothelial lipase to facilitate their post-translational folding, dimerization, and catalytic activation; its expression is transcriptionally upregulated by ER stress via the ATF6α branch of the UPR, and loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in both mice and humans."},"narrative":{"teleology":[{"year":2007,"claim":"Positional cloning of the mouse cld mutation identified LMF1 as a previously unknown ER-localized factor required for lipase maturation, solving the decades-old mystery of why cld mice lacked both LPL and hepatic lipase activity, and establishing that human LMF1 loss-of-function causes combined lipase deficiency with hypertriglyceridemia.","evidence":"Positional cloning in cld mice, ER localization, lipase activity assays, identification of homozygous human LMF1 mutation","pmids":["17994020"],"confidence":"High","gaps":["Topology and domain architecture of LMF1 unknown","Whether LMF1 acts on lipases beyond LPL and hepatic lipase not tested","Mechanism of lipase-LMF1 interaction not defined"]},{"year":2009,"claim":"Mapping LMF1's five-transmembrane topology and showing that its ER-luminal loop C within the DUF1222 domain directly contacts LPL and hepatic lipase established the structural basis for its chaperone function.","evidence":"Glycosylation site tagging, GFP fusions, co-immunoprecipitation with DUF1222 truncation variants","pmids":["19783858"],"confidence":"High","gaps":["No high-resolution structure of LMF1 or LMF1-lipase complex","Whether other DUF1222 sub-domains contribute to lipase binding not resolved","Stoichiometry of LMF1-lipase interaction unknown"]},{"year":2012,"claim":"Transgenic overexpression of Lmf1 in adipose and muscle increased LPL activity in vivo, demonstrating that LMF1 abundance is rate-limiting for lipase maturation and not merely permissive, while separate studies showed LMF1 expression is constitutive and does not respond to feeding/fasting cycles.","evidence":"aP2-Lmf1 and Mck-Lmf1 transgenic mice with tissue-specific LPL activity measurements; cycloheximide/actinomycin D chase and qPCR in rat adipose tissue","pmids":["22345169","23176178"],"confidence":"High","gaps":["How LMF1 protein turnover is regulated remains unclear","Whether LMF1 overexpression affects hepatic or endothelial lipase activity in vivo not tested"]},{"year":2014,"claim":"Two advances broadened LMF1's substrate range and regulatory context: LMF1-null mice revealed that endothelial lipase also requires LMF1 for maturation and that complete loss causes neonatal lethality, while mechanistic dissection showed that ER stress induces LMF1 transcription specifically via ATF6α acting on a GC-rich promoter element.","evidence":"LMF1-null mouse characterization with lipase assays; ATF6α knockout MEFs and mouse liver, luciferase reporters, tunicamycin treatment, dominant-negative ATF6α","pmids":["25302068","25035425"],"confidence":"High","gaps":["Whether LMF1 has substrates beyond the three vascular lipases unknown","Functional significance of ATF6α-mediated LMF1 induction for lipase homeostasis in vivo not demonstrated","Cause of neonatal lethality beyond lipase deficiency not dissected"]},{"year":2018,"claim":"Cell-based functional assays of patient-derived LMF1 missense and nonsense variants quantified their impact on LPL activation, linking specific residues to chaperone function and establishing a framework for clinical variant interpretation.","evidence":"Co-transfection of HEK-293T cells with LMF1 variants and LPL, LPL activity measured with VLDL-TG substrate","pmids":["30037590"],"confidence":"Medium","gaps":["Mechanism by which individual residues contribute to chaperone activity not resolved","Effects on hepatic lipase and endothelial lipase not tested for these variants","No in vivo validation of variant pathogenicity"]},{"year":2024,"claim":"Further variant analysis distinguished two pathogenic mechanisms: some LMF1 mutations reduce intrinsic chaperone specific activity while others additionally decrease LMF1 protein expression, revealing that both protein stability and functional competence independently contribute to disease.","evidence":"Transient transfection of HEK293 cells, LPL activity assay, LMF1 protein expression quantification","pmids":["39537501"],"confidence":"Medium","gaps":["No structural explanation for why specific variants reduce chaperone activity","Whether reduced LMF1 protein expression reflects ER-associated degradation not tested","Genotype-phenotype correlation in patient cohorts not established"]},{"year":null,"claim":"Key unresolved questions include the structural mechanism by which LMF1 loop C promotes lipase folding and dimerization, whether LMF1 has client proteins beyond the three vascular lipases, and how ATF6α-mediated transcriptional induction integrates with lipase homeostasis in vivo.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of LMF1 or LMF1-lipase complex","Full client spectrum of LMF1 not defined","Physiological relevance of UPR-driven LMF1 induction for lipid metabolism in vivo unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,7]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,7]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,7]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,4]}],"complexes":[],"partners":["LPL","LIPC","LIPG","ATF6"],"other_free_text":[]},"mechanistic_narrative":"LMF1 is an endoplasmic reticulum-resident transmembrane chaperone essential for the post-translational folding, dimerization, and catalytic activation of the vascular lipases LPL, hepatic lipase, and endothelial lipase [PMID:17994020, PMID:25302068]. It adopts a five-transmembrane topology with an evolutionarily conserved DUF1222 domain, and its luminal loop C physically interacts with nascent lipases to promote their maturation [PMID:19783858]. LMF1 expression is transcriptionally upregulated during ER stress via the ATF6α branch of the unfolded protein response through a GC-rich promoter element [PMID:25035425], yet it functions as a constitutive chaperone whose expression does not fluctuate with acute metabolic cues such as feeding and fasting [PMID:23176178]. Loss-of-function mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans [PMID:17994020, PMID:25302068]."},"prefetch_data":{"uniprot":{"accession":"Q96S06","full_name":"Lipase maturation factor 1","aliases":["Transmembrane protein 112"],"length_aa":567,"mass_kda":64.9,"function":"Involved in the maturation of specific proteins in the endoplasmic reticulum. Required for maturation and transport of active lipoprotein lipase (LPL) through the secretory pathway. Each LMF1 molecule chaperones 50 or more molecules of LPL","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q96S06/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LMF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LMF1","total_profiled":1310},"omim":[{"mim_id":"615947","title":"HYPERLIPOPROTEINEMIA, TYPE ID","url":"https://www.omim.org/entry/615947"},{"mim_id":"612757","title":"GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1","url":"https://www.omim.org/entry/612757"},{"mim_id":"611761","title":"LIPASE MATURATION FACTOR 1; LMF1","url":"https://www.omim.org/entry/611761"},{"mim_id":"246650","title":"LIPASE DEFICIENCY, COMBINED","url":"https://www.omim.org/entry/246650"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LMF1"},"hgnc":{"alias_symbol":["FLJ12681","JFP11","FLJ22302","TMEM112A"],"prev_symbol":["C16orf26","TMEM112"]},"alphafold":{"accession":"Q96S06","domains":[{"cath_id":"-","chopping":"51-351_363-406","consensus_level":"medium","plddt":95.2698,"start":51,"end":406},{"cath_id":"-","chopping":"417-560","consensus_level":"high","plddt":95.566,"start":417,"end":560}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S06","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S06-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S06-F1-predicted_aligned_error_v6.png","plddt_mean":90.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LMF1","jax_strain_url":"https://www.jax.org/strain/search?query=LMF1"},"sequence":{"accession":"Q96S06","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96S06.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96S06/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S06"}},"corpus_meta":[{"pmid":"22239554","id":"PMC_22239554","title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.","date":"2012","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22239554","citation_count":201,"is_preprint":false},{"pmid":"17994020","id":"PMC_17994020","title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17994020","citation_count":167,"is_preprint":false},{"pmid":"23176178","id":"PMC_23176178","title":"Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue.","date":"2012","source":"BMC physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23176178","citation_count":67,"is_preprint":false},{"pmid":"19820022","id":"PMC_19820022","title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.","date":"2009","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19820022","citation_count":54,"is_preprint":false},{"pmid":"36314270","id":"PMC_36314270","title":"IMC10 and LMF1 mediate mitochondrial morphology through mitochondrion-pellicle contact sites in Toxoplasma gondii.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/36314270","citation_count":32,"is_preprint":false},{"pmid":"30037590","id":"PMC_30037590","title":"New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.","date":"2018","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/30037590","citation_count":24,"is_preprint":false},{"pmid":"19783858","id":"PMC_19783858","title":"Lipase maturation factor LMF1, membrane topology and interaction with lipase proteins in the endoplasmic reticulum.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19783858","citation_count":23,"is_preprint":false},{"pmid":"28391895","id":"PMC_28391895","title":"Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.","date":"2017","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/28391895","citation_count":21,"is_preprint":false},{"pmid":"30885219","id":"PMC_30885219","title":"Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking.","date":"2019","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/30885219","citation_count":21,"is_preprint":false},{"pmid":"22345169","id":"PMC_22345169","title":"Transgenic expression and genetic variation of Lmf1 affect LPL activity in mice and humans.","date":"2012","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22345169","citation_count":18,"is_preprint":false},{"pmid":"25035425","id":"PMC_25035425","title":"Lipase maturation factor 1 (lmf1) is induced by endoplasmic reticulum stress through activating transcription factor 6α (Atf6α) signaling.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25035425","citation_count":13,"is_preprint":false},{"pmid":"25302068","id":"PMC_25302068","title":"Embryonic viability, lipase deficiency, hypertriglyceridemia and neonatal lethality in a novel LMF1-deficient mouse model.","date":"2014","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25302068","citation_count":12,"is_preprint":false},{"pmid":"35246399","id":"PMC_35246399","title":"Severe hypertriglyceridemia secondary to splice-site and missense variants in LMF1 in three patients from Ecuador.","date":"2022","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/35246399","citation_count":7,"is_preprint":false},{"pmid":"35368694","id":"PMC_35368694","title":"A Heterozygous LMF1 Gene Mutation (c.1523C>T), Combined With an LPL Gene Mutation (c.590G>A), Aggravates the Clinical Symptoms in Hypertriglyceridemia.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35368694","citation_count":6,"is_preprint":false},{"pmid":"33039347","id":"PMC_33039347","title":"Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia.","date":"2020","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/33039347","citation_count":6,"is_preprint":false},{"pmid":"32190547","id":"PMC_32190547","title":"Genetic and functional studies of the LMF1 gene in Thai patients with severe hypertriglyceridemia.","date":"2020","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/32190547","citation_count":5,"is_preprint":false},{"pmid":"38462482","id":"PMC_38462482","title":"Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review.","date":"2024","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/38462482","citation_count":5,"is_preprint":false},{"pmid":"25817768","id":"PMC_25817768","title":"[Identification of variants in LMF1 gene associated with primary hypertriglyceridemia].","date":"2015","source":"Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/25817768","citation_count":5,"is_preprint":false},{"pmid":"39537501","id":"PMC_39537501","title":"Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia.","date":"2024","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/39537501","citation_count":1,"is_preprint":false},{"pmid":"34062067","id":"PMC_34062067","title":"Assessment of Zinc- alpha2 glycoprotein (ZAG) and Lipase Maturation Factor 1 (LMF1) concentration in children with chronic kidney disease.","date":"2021","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/34062067","citation_count":1,"is_preprint":false},{"pmid":"41997320","id":"PMC_41997320","title":"Single-cell transcriptomic analysis reveals novel lncRNA macromolecules associated with PARP11, LMF1, and RRM2 regulatory axes in non-small cell lung cancer.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41997320","citation_count":0,"is_preprint":false},{"pmid":"40142634","id":"PMC_40142634","title":"Identification of a Pathogenic Mutation of the Lipase Maturation Factor 1 (LMF1) Gene Causing Recurrent Pancreatitis and Requiring Critical Care.","date":"2025","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40142634","citation_count":0,"is_preprint":false},{"pmid":"41633911","id":"PMC_41633911","title":"Homozygous variant in LMF-1 identified in 3 Colombian families.","date":"2026","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/41633911","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13760,"output_tokens":2105,"usd":0.036428},"stage2":{"model":"claude-opus-4-6","input_tokens":5400,"output_tokens":2041,"usd":0.117038},"total_usd":0.153466,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"LMF1 (encoded by Tmem112/Lmf1) is a transmembrane protein localized to the endoplasmic reticulum (ER) that is required for post-translational maturation of lipoprotein lipase (LPL) and hepatic lipase (HL); loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in mice (cld mutation) and humans.\",\n      \"method\": \"Positional cloning of cld mutation, ER localization studies, lipase activity assays in mice and human patient with homozygous LMF1 mutation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original discovery with multiple orthogonal methods (positional cloning, localization, biochemical activity), replicated in mouse and human\",\n      \"pmids\": [\"17994020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LMF1 adopts a five-transmembrane topology in the ER membrane, dividing it into six domains: three cytoplasmic (N-terminal domain, loops B and D) and three ER-luminal (loops A and C, C-terminal domain). The evolutionarily conserved DUF1222 domain spans four of these six domains, and LMF1 physically interacts with LPL and hepatic lipase through loop C within DUF1222.\",\n      \"method\": \"Ectopic glycan attachment site tagging, GFP terminal fusion, naturally occurring DUF1222 truncation variants, co-immunoprecipitation/pulldown assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — topology established by multiple experimental strategies (glycosylation tagging + GFP fusions), interaction site mapped by loss-of-function variants\",\n      \"pmids\": [\"19783858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Overexpression of Lmf1 in adipose tissue (aP2-Lmf1 transgenic) and muscle (Mck-Lmf1 transgenic) increases LPL activity in vivo, demonstrating that variation in Lmf1 expression is a post-translational determinant of LPL activity beyond its role as a required maturation factor.\",\n      \"method\": \"Transgenic mouse generation and characterization; LPL activity and mass measurements in multiple tissues; association of LMF1 gene variants with post-heparin LPL activity in human dyslipidemic cohort\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean transgenic gain-of-function with defined biochemical phenotype in multiple tissues, supported by human genetic association\",\n      \"pmids\": [\"22345169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LMF1 expression is induced by ER stress via the ATF6α arm of the unfolded protein response (UPR); ATF6α is both sufficient and necessary for activation of the Lmf1 promoter through a GC-rich cis-regulatory element 264 bp upstream of the transcriptional start site.\",\n      \"method\": \"Genetic deficiency in mouse embryonic fibroblasts and mouse liver, luciferase reporter assays, tunicamycin-treated mice, dominant-negative ATF6α, ATF6α knockout\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic dissection using genetic ablation, reporter assays, and dominant-negative approaches across multiple cell types\",\n      \"pmids\": [\"25035425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LMF1 is required for maturation of endothelial lipase (EL) in addition to LPL and hepatic lipase; LMF1-null mice (complete knockout) are born at Mendelian ratios but exhibit combined lipase deficiency, hypertriglyceridemia, and neonatal lethality, confirming LMF1 is dispensable for embryonic but not postnatal survival.\",\n      \"method\": \"LMF1-null mouse generation, in situ hybridization, qPCR, lipase activity assays\",\n      \"journal\": \"Nutrition & metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean null allele with defined biochemical (lipase deficiency) and physiological (neonatal lethality) phenotype\",\n      \"pmids\": [\"25302068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Specific LMF1 missense variants (p.Gly172Arg, p.Arg354Trp, p.Arg364Gln, p.Arg537Trp) reduce LPL activity in vitro when co-transfected with LPL in HEK-293T cells, while the p.Trp464Ter nonsense variant completely abolishes LPL activity, establishing functional impact at the cellular level.\",\n      \"method\": \"In vitro co-transfection of HEK-293T cells with LMF1 and LPL vectors, LPL activity assay using human VLDL-TG as substrate\",\n      \"journal\": \"Journal of clinical lipidology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based functional assay with direct LPL activity measurement, single lab\",\n      \"pmids\": [\"30037590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Homozygous LMF1 variants (p.Asn147Lys, p.Pro246Arg, p.Arg354Trp, p.Arg364Gln) impair LMF1 function by reducing the specific activity of LMF1 as a chaperone for LPL; p.Asn147Lys additionally reduces LMF1 protein expression itself, revealing distinct molecular mechanisms of pathogenic variants.\",\n      \"method\": \"Transient transfection of HEK293 cells, LPL activity assay, LMF1 protein expression analysis\",\n      \"journal\": \"Journal of clinical lipidology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based functional assay with multiple variants and mechanistic distinction, single lab\",\n      \"pmids\": [\"39537501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LMF1 is an ER protein necessary for folding of LPL into its active dimeric form; its expression in rat adipose tissue does not respond rapidly to feeding/fasting cycles unlike ANGPTL4 and GPIHBP1, indicating its role as a constitutive chaperone rather than a dynamic regulator of LPL activity.\",\n      \"method\": \"Cycloheximide and actinomycin D chase experiments, qPCR, LPL activity assays in rat adipose tissue under feeding/fasting conditions\",\n      \"journal\": \"BMC physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mRNA and protein turnover experiments establishing LMF1 as a constitutive ER chaperone distinct from regulatory proteins\",\n      \"pmids\": [\"23176178\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LMF1 is an ER-resident polytopic chaperone with five transmembrane segments whose luminal DUF1222 domain (specifically loop C) physically interacts with nascent LPL, hepatic lipase, and endothelial lipase to facilitate their post-translational folding, dimerization, and catalytic activation; its expression is transcriptionally upregulated by ER stress via the ATF6α branch of the UPR, and loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in both mice and humans.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LMF1 is an endoplasmic reticulum-resident transmembrane chaperone essential for the post-translational folding, dimerization, and catalytic activation of the vascular lipases LPL, hepatic lipase, and endothelial lipase [PMID:17994020, PMID:25302068]. It adopts a five-transmembrane topology with an evolutionarily conserved DUF1222 domain, and its luminal loop C physically interacts with nascent lipases to promote their maturation [PMID:19783858]. LMF1 expression is transcriptionally upregulated during ER stress via the ATF6α branch of the unfolded protein response through a GC-rich promoter element [PMID:25035425], yet it functions as a constitutive chaperone whose expression does not fluctuate with acute metabolic cues such as feeding and fasting [PMID:23176178]. Loss-of-function mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans [PMID:17994020, PMID:25302068].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Positional cloning of the mouse cld mutation identified LMF1 as a previously unknown ER-localized factor required for lipase maturation, solving the decades-old mystery of why cld mice lacked both LPL and hepatic lipase activity, and establishing that human LMF1 loss-of-function causes combined lipase deficiency with hypertriglyceridemia.\",\n      \"evidence\": \"Positional cloning in cld mice, ER localization, lipase activity assays, identification of homozygous human LMF1 mutation\",\n      \"pmids\": [\"17994020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Topology and domain architecture of LMF1 unknown\",\n        \"Whether LMF1 acts on lipases beyond LPL and hepatic lipase not tested\",\n        \"Mechanism of lipase-LMF1 interaction not defined\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapping LMF1's five-transmembrane topology and showing that its ER-luminal loop C within the DUF1222 domain directly contacts LPL and hepatic lipase established the structural basis for its chaperone function.\",\n      \"evidence\": \"Glycosylation site tagging, GFP fusions, co-immunoprecipitation with DUF1222 truncation variants\",\n      \"pmids\": [\"19783858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of LMF1 or LMF1-lipase complex\",\n        \"Whether other DUF1222 sub-domains contribute to lipase binding not resolved\",\n        \"Stoichiometry of LMF1-lipase interaction unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Transgenic overexpression of Lmf1 in adipose and muscle increased LPL activity in vivo, demonstrating that LMF1 abundance is rate-limiting for lipase maturation and not merely permissive, while separate studies showed LMF1 expression is constitutive and does not respond to feeding/fasting cycles.\",\n      \"evidence\": \"aP2-Lmf1 and Mck-Lmf1 transgenic mice with tissue-specific LPL activity measurements; cycloheximide/actinomycin D chase and qPCR in rat adipose tissue\",\n      \"pmids\": [\"22345169\", \"23176178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How LMF1 protein turnover is regulated remains unclear\",\n        \"Whether LMF1 overexpression affects hepatic or endothelial lipase activity in vivo not tested\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Two advances broadened LMF1's substrate range and regulatory context: LMF1-null mice revealed that endothelial lipase also requires LMF1 for maturation and that complete loss causes neonatal lethality, while mechanistic dissection showed that ER stress induces LMF1 transcription specifically via ATF6α acting on a GC-rich promoter element.\",\n      \"evidence\": \"LMF1-null mouse characterization with lipase assays; ATF6α knockout MEFs and mouse liver, luciferase reporters, tunicamycin treatment, dominant-negative ATF6α\",\n      \"pmids\": [\"25302068\", \"25035425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether LMF1 has substrates beyond the three vascular lipases unknown\",\n        \"Functional significance of ATF6α-mediated LMF1 induction for lipase homeostasis in vivo not demonstrated\",\n        \"Cause of neonatal lethality beyond lipase deficiency not dissected\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Cell-based functional assays of patient-derived LMF1 missense and nonsense variants quantified their impact on LPL activation, linking specific residues to chaperone function and establishing a framework for clinical variant interpretation.\",\n      \"evidence\": \"Co-transfection of HEK-293T cells with LMF1 variants and LPL, LPL activity measured with VLDL-TG substrate\",\n      \"pmids\": [\"30037590\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which individual residues contribute to chaperone activity not resolved\",\n        \"Effects on hepatic lipase and endothelial lipase not tested for these variants\",\n        \"No in vivo validation of variant pathogenicity\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Further variant analysis distinguished two pathogenic mechanisms: some LMF1 mutations reduce intrinsic chaperone specific activity while others additionally decrease LMF1 protein expression, revealing that both protein stability and functional competence independently contribute to disease.\",\n      \"evidence\": \"Transient transfection of HEK293 cells, LPL activity assay, LMF1 protein expression quantification\",\n      \"pmids\": [\"39537501\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural explanation for why specific variants reduce chaperone activity\",\n        \"Whether reduced LMF1 protein expression reflects ER-associated degradation not tested\",\n        \"Genotype-phenotype correlation in patient cohorts not established\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural mechanism by which LMF1 loop C promotes lipase folding and dimerization, whether LMF1 has client proteins beyond the three vascular lipases, and how ATF6α-mediated transcriptional induction integrates with lipase homeostasis in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of LMF1 or LMF1-lipase complex\",\n        \"Full client spectrum of LMF1 not defined\",\n        \"Physiological relevance of UPR-driven LMF1 induction for lipid metabolism in vivo unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"LPL\", \"LIPC\", \"LIPG\", \"ATF6\"],\n    \"other_free_text\": []\n  }\n}\n```"}